NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea · Delayed Price · Currency is KRW 17,170
-10 (-0.06%)
Apr 10, 2026, 3:30 PM KST
NeoPharm CO., LTD. Revenue
In the year 2025, NeoPharm CO., LTD. had annual revenue of 132.18B KRW with 11.07% growth. NeoPharm CO., LTD. had revenue of 36.40B in the quarter ending December 31, 2025, with 6.97% growth.
Revenue
132.18B
Revenue Growth
+11.07%
P/S Ratio
2.03
Revenue / Employee
742.61M
Employees
178
Market Cap
268.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 132.18B | 13.17B | 11.07% |
| Dec 31, 2024 | 119.01B | 21.91B | 22.56% |
| Dec 31, 2023 | 97.10B | 12.07B | 14.20% |
| Dec 31, 2022 | 85.03B | -2.90B | -3.30% |
| Dec 31, 2021 | 87.93B | 6.31B | 7.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aekyung Industrial | 654.53B |
| Kolmar Holdings | 630.11B |
| KOLMAR BNH | 574.88B |
| VT Co., Ltd. | 437.18B |
| Able C&C | 242.00B |
| Tonymoly | 220.27B |
| It'S Hanbul | 153.39B |
| Monalisa | 140.89B |